Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 3/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 4/20 | 0.33 |
| ▸ | CHRNA9 | Q9UGM1 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL8953824 | 0.97 | CHRNA7 (0.33) | CHRNA7CHRNA10CHRNA9 | |
| Iodide SCHEMBL9055249 | 0.97 | CHRNA7 (0.33) | CHRNA7CHRNA10CHRNA9 | |
| Iodide SCHEMBL8780639 | 0.97 | CHRNA7 (0.33) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL575435 | 0.96 | — | — | |
| SCHEMBL575098 | 0.93 | CHRNA7 (0.34) | CHRNA7 | |
| Water SCHEMBL16297127 | 0.93 | CHRNA7 (0.34) | CHRNA7 | |
| SCHEMBL19307694 | 0.93 | CHRNA7 (0.34) | CHRNA7 | |
| SCHEMBL19307655 | 0.93 | CHRNA7 (0.34) | CHRNA7 | |
| Hydrochloric Acid SCHEMBL15366520 | 0.93 | CHRNA7 (0.34) | CHRNA7 | |
| SCHEMBL2865219 | 0.93 | CHRNA7 (0.34) | CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113471527-A | Solid polymer electrolyte, preparation method and application thereof | 绍兴熠研科技发展有限公司 | 2021-10-01 | — | — | CN | disclosed |
| US-9550684-B2 | Process for making molecular sieves | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-01-24 | — | — | US | disclosed |
| EP-3008015-A1 | A PROCESS FOR MAKING MOLECULAR SIEVES | ExxonMobil Chemical Patents Inc. (US) | 2016-04-20 | — | — | EP | disclosed |
| US-20160090308-A1 | A Process for Making Molecular Sieves | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-03-31 | — | — | US | disclosed |
| WO-2014200633-A1 | A PROCESS FOR MAKING MOLECULAR SIEVES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-12-18 | — | — | WO | disclosed |
| EP-0391370-B1 | Epoxy resins | CIBA GEIGY AG (CH) | 1996-07-03 | — | — | EP | disclosed |
| EP-0362140-B1 | Epoxy resin composition | CIBA GEIGY AG (CH) | 1995-11-22 | — | — | EP | disclosed |
| US-5019639-A | Chain extension with aliphatic diol and phenolic diol, coatings, lamination, pregregs, low viscosity | CIBA-GEIGY CORPORATION (US) | 1991-05-28 | — | — | US | disclosed |
| US-5006626-A | Epoxy resin compositions | CIBA-GEIGY CORPORATION (US) | 1991-04-09 | — | — | US | disclosed |
| EP-0391370-A2 | Epoxy resins | CIBA-GEIGY AG (CH) | 1990-10-10 | — | — | EP | disclosed |
| EP-0362140-A2 | Epoxy resin composition | CIBA-GEIGY AG (CH) | 1990-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090308-A1 | A Process for Making Molecular Sieves | NPM1, HNRNPM, POLM | CHRNA7 3876/4885CHRNA10 4634/4885CHRNA9 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.